Melanoma Adjuvant Treatment: Current Insight and Clinical Features.
D'Aniello C, Perri F, Scarpati GDV, Pepa CD, Pisconti S, Montesarchio V, Wernert N, Zarone MR, Caraglia M, Facchini G, Berretta M, Cavaliere C.
D'Aniello C, et al. Among authors: perri f.
Curr Cancer Drug Targets. 2018;18(5):442-456. doi: 10.2174/1568009617666170208163714.
Curr Cancer Drug Targets. 2018.
PMID: 28183255
Review.